Prof. Paresh Vyas is a Professor of Hematology at the University of Oxford with over 25 years of experience specializing in myeloid disorders, including AML. He serves as Deputy Director of the MRC Molecular Haematology Unit and is a member of the UK AML and MDS clinical trials group, with expertise spanning early-phase trial design and translational research. He co-founded the international EVOLVE consortium, which delivers innovative AML clinical trials, and established Oxford’s Therapy Acceleration Laboratory (TAL), a state-of-the-art facility supporting centralized laboratory analyses for clinical trials from Phase I through Phase III.